Bifogade filer
PDF
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Today, Bio-Works confirmed a new orders for WorkBeads affimAb - a product used in the purification of therapeutic antibodies for use in pharmaceutical production. The total order value amounts to 11.2 million SEK. The orders will be delivered as three separate shipments during the Q1-Q3, 2025.
"These orders confirm that our focus on building partnerships with our process customers is paying off," says Lone Carlbom, CEO of Bio-Works.
"This customer has now integrated WorkBeads affimAb into several processes, which reinforces that our products are of high quality and that Bio-Works brings value to our customers."
WorkBeads affimAb is a modern affinity resin well-suited for large-scale purification of monoclonal antibodies, and these orders are the result of a letter of intent that Bio-Works communicated earlier this quarter.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on "Innehållet inom klamrarna kommer ersättas med rätt tid och datum vid utskickstillfället">14-01-2025 13:33 CET.